Why it matters
Our scientific team presents a comprehensive framework for systematic target deconvolution strategies in cell-based phenotypic programs, integrating chemo-proteomics, genetic perturbation, and computational approaches.
Scientific context
Discovery programs increasingly require decision-grade data that connects target biology, modality strategy, translational relevance, and operational timing. AstraNova structures each platform update and scientific resource around that decision framework.
Partner impact
For biotech and pharmaceutical teams, the practical value is faster experimental alignment, clearer risk interpretation, and more confident movement between discovery milestones without sacrificing rigor.

